# Efficacy, Safety and Pharmacokinetic Profile of a Collagen Bupivacaine Implant in Men After Open Mesh Herniorrhaphy

> **NCT00626886** · PHASE2 · COMPLETED · sponsor: **Innocoll** · enrollment: 53 (actual)

## Conditions studied

- Postoperative Pain
- Inguinal Hernia

## Interventions

- **DRUG:** Bupivacaine Collagen Sponge
- **DRUG:** placebo collagen sponge

## Key facts

- **NCT ID:** NCT00626886
- **Lead sponsor:** Innocoll
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-11
- **Primary completion:** 2009-01-29
- **Final completion:** 2009-01-29
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2021-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00626886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00626886, "Efficacy, Safety and Pharmacokinetic Profile of a Collagen Bupivacaine Implant in Men After Open Mesh Herniorrhaphy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00626886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
